dmv.community is one of the many independent Mastodon servers you can use to participate in the fediverse.
A small regional Mastodon instance for those in the DC, Maryland, and Virginia areas. Local news, commentary, and conversation.

Administered by:

Server stats:

162
active users

#Influenza

4 posts4 participants0 posts today

Promising: "Cornell University researchers have developed a new vaccine platform designed to offer stronger, longer-lasting protection against both COVID & influenza while providing broader immunity against various flu strains.

A study published in Science Advances found that vaccinated mice showed no visible signs of illness & exhibited no cellular damage in their tissues."

#USPol #Health #Vaccines #Covid #Influenza

scitechdaily.com/game-changing

#Risk to #People in #USA from Highly Pathogenic Avian #Influenza A(#H5N1) Viruses, US CDC as of Feb. 28 '25: cdc.gov/cfa-qualitative-assess

The current risk to the general U.S. population is low. The risk to populations exposed to potentially infected animals, including through contaminated surfaces or fluids, is currently assessed as moderate to high. CDC has moderate confidence in this assessment.

CFA: Qualitative AssessmentsRisk to People in the United States from Highly Pathogenic Avian Influenza A(H5N1) VirusesBy CDC

#covid #flu #influenza #vaccines #PublicHealth

'Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains.

In a study published Jan. 29 in Science Advances, researchers found no visible signs of illness in mouse models after vaccination with the new platform and no cellular damage to tissues.'

news.cornell.edu/stories/2025/

syringe and vaccine
Cornell ChronicleCOVID-flu vaccine could provide broad, lasting protection | Cornell ChronicleThe new platform, which provided 100% protection from influenza and COVID-19 in mouse models, could vastly improve vaccine administration and the efficacy of the current flu vaccine.

From the link:
“Question  What is the relative severity of illness caused by SARS-CoV-2, influenza, and respiratory syncytial virus (RSV)?
Findings  In this cohort study of more than 141 000 nonhospitalized US veterans who were concurrently tested for all 3 viruses and diagnosed with a single infection between August 2022 and March 2023 or between August 2023 and March 2024, RSV was associated with lower 30-day risk of hospitalization, and COVID-19 was associated with a higher risk of long-term mortality through 180 days.
Meaning  COVID-19 was associated with more severe disease outcomes, including long-term mortality, compared with influenza or RSV.”
jamanetwork.com/journals/jamai

"The Food and Drug Administration was allowed to participate in the World Health Organization's meeting this week on updating influenza shots, officials for the U.N. agency said, despite an order by President Trump last month banning government employees from working with the WHO. The administration has granted some exemptions to the order."

cbsnews.com/news/fda-who-flu-s

www.cbsnews.comFDA allowed to help WHO update flu shots, despite Trump banA World Health Organization official said the FDA "participated as in the past" in the process.